The Kelman Duet phakic intraocular lens: 1-year results.
OBJECTIVE
To evaluate the efficacy and safety of the Kelman Duet phakic intraocular lens (PIOL) for correction of moderate and high myopia.


METHODS
Kelman Duet PIOLs were implanted in 169 eyes of 110 patients with moderate or high myopia. In all cases, implantation of the lens was feasible through an incision of less than 2.5 mm without complications. Uncorrected visual acuity (UCVA), manifest refraction, best spectacle-corrected visual acuity (BSCVA), intraocular pressure, central corneal endothelial change, and complications were recorded preoperatively and during 12 months of follow-up.


RESULTS
Following PIOL implantation, 23 (13.61%) eyes required LASIK retreatment for the correction of residual astigmatic refractive error and were excluded from the refractive analysis. Best spectacle-corrected visual acuity remained the same or improved in 95.04% of eyes, 81.30% of eyes (100) were within +/-1.00 diopter (D) of emmetropia, and 57.72% (71) were within +/-0.50 D. Intraocular pressure increased slightly in the first 4 weeks postoperatively but stabilized to the preoperative level by 3 months. Mean endothelial cell loss at 12 months was 5.43%. Oval pupils developed in 10.1% of eyes. Haptic exchange or reposition was performed in 7.76% of cases.


CONCLUSIONS
The Kelman Duet PIOL was safe and effective for the correction of moderate to high myopia in this study with 1-year follow-up and offered the advantage of using a 2.5-mm or less incision width. Accurate haptic sizing remains a challenge and haptic exchange to correct haptic size mismatching is possible.
Vissum/Instituto Oftalmológico de Alicante, Alicante, Spain. jlalio@vissum.com
Jorge L
JL
Alió
David
D
Piñero
Gonzalo
G
Bernabeu
Ahmed
A
Galal
José Manuel
JM
Vargas
Mahmoud M
MM
Ismail
D000328:Adult; D000869:Anterior Eye Segment / Q000000981:diagnostic imaging; D004728:Endothelium, Corneal / Q000473:pathology; D004867:Equipment Design; D005139:Eyeglasses; D005500:Follow-Up Studies; D006801:Humans; D007429:Intraocular Pressure; D007498:Iris / Q000473:pathology; D020731:Keratomileusis, Laser In Situ; D019654:Lens Implantation, Intraocular / Q000009:adverse effects; D009216:Myopia / Q000503:physiopathology / Q000601:surgery*; D054120:Phakic Intraocular Lenses / Q000009:adverse effects / Q000592:standards; D011184:Postoperative Period; D011446:Prospective Studies; D012029:Refraction, Ocular; D012086:Reoperation; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014463:Ultrasonography; D014792:Visual Acuity